172470-04-1Relevant articles and documents
HETEROARYL INHIBITORS OF PDE4
-
Paragraph 0542, (2014/05/24)
The present invention relates to compounds and methods useful as inhibitors of phosphodiesterase 4 (PDE4) for the treatment or prevention of disease.
2-pyridinone derivatives, having HIV inhibiting properties
-
Page/Page column 6, (2008/06/13)
The present invention relates to 2-Pyridinone derivatives, more specifically 5-ethyl-6-methyl-2-pyridinone derivatives, according to general formula I that inhibit human immunodeficiency virus type 1 (HIV-1) replication and are therefore of interest in th
A new series of pyridinone derivatives as potent non-nucleoside human immunodeficiency virus type 1 specific reverse transcriptase inhibitors
Dolle,Fan,Chi Hung Nguyen,Aubertin,Kirn,Andreola,Jamieson,Tarrago-Litvak,Bisagni
, p. 4679 - 4686 (2007/10/03)
4-(Arylthio)-pyridin-2(1H)-ones variously substituted in their 3-, 5-, and 6-positions have been synthesized as a new series of 1-[(2- hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT)-pyridinone hybrid molecules. Biological studies revealed that some of them show potent HIV-1 specific reverse transcriptase inhibitory properties. Compounds 16 and 7c, the most active ones, inhibit the replication of HIV-1 at 3 and 6 nM, respectively.